Aberrant localization of β-catenin correlates with overexpression of its target gene in human papillary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 7, 2002, Pages 3433-3440

  Ishigaki, Katsu ^a   Namba, Hiroyuki ^a,e   Nakashima, Masahiro ^c   Nakayama, Toshiyuki ^d   Mitsutake, Norisato ^a   Hayashi, Tomayoshi ^e   Maeda, Shigeto ^f   Ichinose, Makoto ^b   Kanematsu, Takashi ^a   Yamashita, Shunichi ^a  

^a Department of Molecular Medicine ^*

^b Tissue and Histopathology Section   (Japan)

^c Atomic Bomb Disease Institute   (Japan)

^d Departments of Pathology

^e NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF NAGASAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ARTICLE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; ONCOGENE C MYC; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPORTER GENE; SAMPLING; THYROID CANCER; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR LOCALIZATION;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CARCINOMA, PAPILLARY; CELLS, CULTURED; CYCLIN D1; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEINS; REPRESSOR PROTEINS; TCF TRANSCRIPTION FACTORS; THYROID NEOPLASMS; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 18444393396     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.7.3433     Document Type: Article

References (45)

1. The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila
2. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin
3. Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway
4. Catenins, Wnt signaling and cancer
5. Identification of c-MYC as a target of the APC pathway
6. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
7. Control of β-catenin signaling in tumor development
8. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1
9. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
10. A common human skin tumour is caused by activating mutations in β-catenin
11. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
12. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
13. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling
14. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice
15. Adenomatous polyposis: An association with carcinoma of the thyroid
16. Papillary thyroid carcinoma in Danish patients with familial adenomatous polyposis
17. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma
18. Expression of the myc cellular proto-oncogene in human thyroid tissue
19. Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas
20. Interleukin-1 production and action in thyroid tissue
21. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms
22. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: Results from a European cooperative study
23. Wnt signaling and cancer
24. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene m the mammary epithelium of int-2/Fgf-3 transgenic mice
25. Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain
26. Transformation by Wnt family proteins correlates with regulation of betacatenin
27. A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals
28. Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability
29. Nuclear endpoint of Writ signaling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1
30. β- and γ-catenin expression in thyroid carcinomas
31. Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue
32. β-catenin dysregulation in thyroid neoplasms: Down-regulation, aberrant nuclear expression, and ctnnb1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis
33. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
34. Cadherin-mediated adhesion and apical membrane assembly define distinct steps during thyroid epithelial polarization and lumen formation
35. Remodeling the cell surface distribution of membrane proteins during the development of epithelial cell polarity
36. E-cadherin: A differentiation marker in thyroid malignancies
37. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas
38. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue
39. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome
40. Regulation of the cell-cell adhesion protein, E-cadherin, in dog and human thyrocytes in vitro
41. Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line
42. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas
43. The multistep nature of cancer
44. cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid
45. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid